Literature DB >> 26132673

Choosing medications for treatment-resistant depression based on mechanism of action.

Michael E Thase, Thomas L Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26132673     DOI： 10.4088/JCP.14052ah2c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  7 in total

Review 1.  Molecular Mechanisms Associated with Antidepressant Treatment on Major Depression.

Authors:  Lívia Ramos-da-Silva; Pamela T Carlson; Licia C Silva-Costa; Daniel Martins-de-Souza; Valéria de Almeida
Journal:  Complex Psychiatry       Date:  2021-07-09

Review 2.  Treatment resistant depression: A multi-scale, systems biology approach.

Authors:  Huda Akil; Joshua Gordon; Rene Hen; Jonathan Javitch; Helen Mayberg; Bruce McEwen; Michael J Meaney; Eric J Nestler
Journal:  Neurosci Biobehav Rev       Date:  2017-08-30       Impact factor: 8.989

3.  Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.

Authors:  Maurizio Fava; Takao Okame; Yuki Matsushima; Pamela Perry; Emmanuelle Weiller; Ross A Baker
Journal:  Int J Neuropsychopharmacol       Date:  2017-01-01       Impact factor: 5.176

4.  Characterization of gut microbiome in mice model of depression with divergent response to escitalopram treatment.

Authors:  Jiajia Duan; Yu Huang; Xunmin Tan; Tingjia Chai; Jing Wu; Hanping Zhang; Yifan Li; Xi Hu; Peng Zheng; Ping Ji; Libo Zhao; Deyu Yang; Liang Fang; Jinlin Song; Peng Xie
Journal:  Transl Psychiatry       Date:  2021-05-20       Impact factor: 6.222

5.  Brain proteome-wide association study implicates novel proteins in depression pathogenesis.

Authors:  Thomas S Wingo; Yue Liu; Ekaterina S Gerasimov; Jake Gockley; Benjamin A Logsdon; Duc M Duong; Eric B Dammer; Adriana Lori; Paul J Kim; Kerry J Ressler; Thomas G Beach; Eric M Reiman; Michael P Epstein; Philip L De Jager; James J Lah; David A Bennett; Nicholas T Seyfried; Allan I Levey; Aliza P Wingo
Journal:  Nat Neurosci       Date:  2021-04-12       Impact factor: 28.771

6.  Expression and Activity of Metalloproteinases in Depression.

Authors:  Kinga Bobińska; Janusz Szemraj; Piotr Czarny; Piotr Gałecki
Journal:  Med Sci Monit       Date:  2016-04-21

7.  The functional variant rs334558 of GSK3B is associated with remission in patients with depressive disorders.

Authors:  Anastasia Levchenko; Innokentiy S Losenkov; Natalia M Vyalova; German G Simutkin; Nikolay A Bokhan; Bob Wilffert; Anton Jm Loonen; Svetlana A Ivanova
Journal:  Pharmgenomics Pers Med       Date:  2018-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.